New stock news | Beijing Tongrentang applies for listing on the Hong Kong Stock Exchange.
According to the disclosure by the Hong Kong Stock Exchange on January 26, Beijing Tongrentang Medical and Care Investment Co., Ltd. (hereinafter referred to as "Tongrentang Medical and Care") submitted an application for listing on the main board of the Hong Kong Stock Exchange, with China International Capital Corporation Limited as its sponsor.
According to the disclosure by the Hong Kong Stock Exchange on January 26th, Beijing Tongrentang Medical Investment Co., Ltd. (referred to as Beijing Tongrentang Medical) has submitted its application for listing on the main board of the Hong Kong Stock Exchange, with CICC as its sponsor. The prospectus shows that Beijing Tongrentang Medical is a subsidiary of Beijing Tongrentang that strategically focuses on Chinese traditional medical services, providing comprehensive Chinese medical services to individual customers, standardized management services to institutional customers, as well as various health and other products. The company has established a tiered Chinese medical service network, including 12 self-owned offline medical institutions and an internet hospital, as well as 12 offline management medical institutions. Based on the total outpatient and inpatient visits in 2024, the company is the largest traditional Chinese medical group in the non-public traditional Chinese medical service industry in China, with a market share of 1.7%.
Related Articles

Guosen: The hotel industry enters a new cycle as leading players reshaping their growth value.

New Stock News | Tumor drug manufacturer Deshengji Medicine plans to list in Hong Kong with a target fundraising amount of $200 million.

HK Stock Market Move | Partial real estate stocks rise in the afternoon, market attention on real estate chain heating up, institutions say to pay attention to early favorable signals in real estate industry.
Guosen: The hotel industry enters a new cycle as leading players reshaping their growth value.

New Stock News | Tumor drug manufacturer Deshengji Medicine plans to list in Hong Kong with a target fundraising amount of $200 million.

HK Stock Market Move | Partial real estate stocks rise in the afternoon, market attention on real estate chain heating up, institutions say to pay attention to early favorable signals in real estate industry.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


